课题基金 / 基金详情

The ligand-affinity molecular cloning of endothelial cell anticoagulant heparin-like compounds

The ligand-affinity molecular cloning of endothelial cell anticoagulant heparin-like compounds
内皮细胞抗凝类肝素化合物的配体亲和分子克隆
批准号:
04454270
负责人:
SHIMADA Kazuyuki
金额:
$4.1万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

SHIMADA Kazuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
本项目的目的是利用配体亲和技术克隆血管内皮细胞表面抗凝血活性硫酸乙酰肝素蛋白聚糖(HSPG)的核心蛋白。我们发现,细胞没有结合到固相抗凝血酶III具有足够高的亲和力细胞分选。在本研究期间,其他研究者也报道了它的克隆。他们的研究结果表明,抗凝HSPG的核心蛋白与非抗凝HSPG的核心蛋白没有区别。那么,内皮细胞合成抗凝糖胺聚糖(glycosaminoglycans,GAG)的确切机制是什么?核心蛋白可能不参与这种特定的代谢调节。为了回答这个问题,我们开发了一个独特的模型,其中抗凝剂(即,抗凝血酶III-亲和力)HSPG特异性缺乏,而总体HSPG代谢没有改变。同型半胱氨酸(Homocysteine,Hcy)是一种特异性抑制HSPG活性的血栓致动脉粥样硬化剂,这种抑制作用是通过氧化还原反应产生自由基来介导的。此外,我们发现,具有自由基清除活性的内皮NO的代谢抑制,显着降低抗凝HSPG对内皮细胞。使用荧光探针证明这伴随着细胞内氢过氧化物的增加。这些结果表明,抗凝血剂HSPG的合成可能受到细胞内自由基活性的调节。内皮源性松弛因子(endothelial-derived relaxant factor,NO)可能通过发挥血管内皮的抗凝作用而具有新的抗血栓活性。
英文摘要
The purpose of this project was originally a molecular cloning of the core protein of anticoagulantly active heparan sulfate proteoglycans (HSPG) on the surface of vascular endotherial cells using a ligand-affinity technique. We found that cells were not bound to the solid-phase antithrombin III with a high affinity enough for cell sorting. During this study, its cloning was reported by other invesigators. Their results suggest that core proteins of anticoagulant HSPG are not different from those of non-anticoagulant HSPG.Then, what is the exact mechanism of the synthesis of anticoagulant glycosaminoglycans (GAG) in endothelial cells? Core proteis may not be involved in this specific metabolic regulation. In order to answer this question, we developed a unique model in which anticoagulant (i.e., antithrombin III-affinity) HSPG is specifically lacking, whereas overall HSPG metabolism is not altered. Homocysteine, a thrombo-atherogenic agent specifically inhibited anticoagulant HSPG.This is mediated by free radical generation via SH-derived redox reaction. Furthermore, we found that the metabolic inhibition of endothelial NO,which has a free radical scavenging activity, markedly reduced the anticoagulant HSPG on endothelial cells. This was demonstrared to be accompanied by an increase in intracellular hydroperoxide using fluorescent probes. These results indicate that the synthesis of anticoagulant HSPG may be regulated by intracellular free radical activities. Endothelium-derived relaxant factor, NO,may have a novel antithrombotic activity by playing an anticoagulant role of the vascular endothelium.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
Nishinaga M,et al: "Recent advanas in endothelial dysfunction in diahetes" Churchill Livingstone,Tokyo, 173-188(286) (1994)
Nishinaga M,et al:“糖尿病内皮功能障碍的最新进展”Churchill Livingstone,Tokyo,173-188(286) (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kario K et al.: "Genetic determinants of plasma factor VII and activated factor VII activity in the Japanese" Thromb.Haemost.(発表予定).
Kario K 等人:“日本人血浆因子 VII 和活化因子 VII 活性的遗传决定因素”Thromb.Haemost。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishinaga M,Ozawa T,Shimada K.: "Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells." J Clin Invest. 92. 1381-1386 (1993)
Nishinaga M、Ozawa T、Shimada K.:“同型半胱氨酸是一种血栓形成剂,可抑制培养的猪主动脉内皮细胞中抗凝硫酸乙酰肝素的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 19 条
    Elucidation of a mechanism of organ tropism in malignant lymphoma to develop novel treatment for intractable extranodal involvement
    • 批准号:
      26860724
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.41万
    • 财政年份:
      2014
    • 负责人:
      SHIMADA Kazuyuki
    • 依托单位:
    Comprehensive research of the human Head and Neck region for the clinical point of view
    • 批准号:
      14370007
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.7万
    • 财政年份:
      2002
    • 负责人:
      SHIMADA Kazuyuki
    • 依托单位:
    Immunohistochemical stuby of the repaired joint arising from transplanting the articular disk in the sternoclavicular joint to the temporomandibular joint.
    • 批准号:
      08671692
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      SHIMADA Kazuyuki
    • 依托单位:
    Stabiligation of vulnerable plaque by gene transter.
    • 批准号:
      08457215
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.06万
    • 财政年份:
      1996
    • 负责人:
      SHIMADA Kazuyuki
    • 依托单位:
    海外基金